Viruses in cancer therapy — from benchwarmers to quarterbacks

Viruses in cancer therapy — from benchwarmers to quarterbacksViruses in cancer therapy — from benchwarmers to quarterbacks, Published online: 29 July 2018; doi:10.1038/s41571-018-0077-0A recent clinical trial of a virotherapy approach, consisting of an engineered poliovirus, has provided evidence of apparently durable responses in patients with recurrent glioblastoma. The results of this trial and others indicate that virotherapy might be an effective tool in anticancer immunotherapy. Yet, caution must be exercised until appropriately powered randomized clinical trials truly show efficacy.
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research